Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in MGNX — Macrogenics Inc

CIK 948046 FRANKFURT AM MAIN, 2M
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$287,968
+$223,081 QoQ
Shares Held
62,331
+22.0% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 122 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. MGNX ranks #218 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in MGNX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $287,968 62,331
2025-03-31 $64,887 51,093
2024-12-31 $4,254 1,309
2024-09-30 $144,282 43,855
2024-06-30 $142,646 33,564
2024-03-31 $579,967 39,400
2023-12-31 $1,811,753 188,332
2023-09-30 $117,222 25,155
2023-06-30 $974,951 182,234
2023-03-31 $1,425,962 198,879
2022-12-31 $1,255,192 187,063
2022-09-30 $85,666 24,759
2022-06-30 $777,622 263,601
2022-03-31 $329,880 37,444
2021-12-31 $661,997 41,246
2021-09-30 $825,851 39,439
2021-06-30 $1,072,384 39,925
2021-03-31 $1,186,633 37,257
2020-12-31 $897,550 39,263
2020-09-30 $751,517 29,834
2020-06-30 $2,106,088 75,433
2020-03-31 $1,145,748 196,864